Raw Material Shortage Holding Up Novavax's COVID-19 Shot Manufacturing, Says Serum Institute<blockquote>血清研究所表示,原材料短缺阻碍了Novavax的COVID-19疫苗生产</blockquote>
Serum Institute of India (SII) is yet to receive raw materials from the U.S. required to produce the